Inventor · disambiguated record
Michael Lutteropp
Also filed as: LUTTEROPP MICHAEL
6 granted patents·41 citations·filing 2015–2024
82Inventor score
Top patents by PatentIndex Score
6 records- 0195US11419935B2Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cellsMILTENYI BIOTEC BV & CO KG·Filed 2021·Granted Aug 23, 2022·5 cites·6 claims
- 0295US11033619B2Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered formMILTENYI BIOTEC GMBH·Filed 2018·Granted Jun 15, 2021·15 cites·11 claims
- 0394US11883494B2Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered formMILTENYI BIOTEC BV & CO KG·Filed 2023·Granted Jan 30, 2024·2 cites·11 claims
- 0493US12246065B2Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigenMILTENYI BIOTEC BV & CO KG·Filed 2024·Granted Mar 11, 2025·1 cites·26 claims
- 0593US10201606B2Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseasesMILTENYI BIOTEC GMBH·Filed 2015·Granted Feb 12, 2019·18 cites·12 claims
- 0688US12318446B2Reducing side effects of immunotherapy using genetically modified hematopoietic cellsMILTENYI BIOTEC BV & CO KG·Filed 2024·Granted Jun 3, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Michael Lutteropp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →